Search research articles
Contact Us
Filters
Showing results (851-860 of 942) with videos related to
Page
of 95
Sort By:
Neurology
|
November 19, 2011
Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype
P Kaufmann, K Engelstad, Y Wei, et al.
Brain : a Journal of Neurology
|
October 9, 2012
Next-generation sequencing reveals DGUOK mutations in adult patients with mitochondrial DNA multiple deletions
Dario Ronchi, Caterina Garone, Andreina Bordoni, et al.
JAMA Neurology
|
February 10, 2015
Deep intronic GBE1 mutation in manifesting heterozygous patients with adult polyglucosan body disease
H Orhan Akman, Or Kakhlon, Jorida Coku, et al.
Molecular Genetics and Metabolism
|
May 23, 2022
Time to harmonize mitochondrial syndrome nomenclature and classification: A consensus from the North American Mitochondrial Disease Consortium (NAMDC)
Valentina Emmanuele, Jaya Ganesh, Georgirene Vladutiu, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 18, 2007
N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR
Holly L Deak, John R Newcomb, Joseph J Nunes, et al.
The Journal of Pediatrics
|
August 4, 1999
The mitochondrial DNA C3303T mutation can cause cardiomyopathy and/or skeletal myopathy
C Bruno, D M Kirby, Y Koga, et al.
Antioxidants (Basel, Switzerland)
|
May 27, 2023
Online Home-Based Physical Activity Counteracts Changes of Redox-Status Biomarkers and Fitness Profiles during Treatment Programs in Postsurgery Female Breast Cancer Patients
Chantalle Moulton, Elisa Grazioli, Cristina Antinozzi, et al.
Nature
|
September 6, 2000
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
I Nishino, J Fu, K Tanji, et al.
Mitochondrion
|
January 13, 2010
Extensive screening system using suspension array technology to detect mitochondrial DNA point mutations
Yutaka Nishigaki, Hitomi Ueno, Jorida Coku, et al.
BMC Structural Biology
|
March 20, 2009
Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study
Maria A Argiriadi, Silvino Sousa, David Banach, et al.
Page
of 95
Search research articles
Search
Showing results (851-860 of 942) with videos related to
Sort By:
Page
of 95
Neurology
|
November 19, 2011
Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype
P Kaufmann, K Engelstad, Y Wei, et al.
Brain : a Journal of Neurology
|
October 9, 2012
Next-generation sequencing reveals DGUOK mutations in adult patients with mitochondrial DNA multiple deletions
Dario Ronchi, Caterina Garone, Andreina Bordoni, et al.
JAMA Neurology
|
February 10, 2015
Deep intronic GBE1 mutation in manifesting heterozygous patients with adult polyglucosan body disease
H Orhan Akman, Or Kakhlon, Jorida Coku, et al.
Molecular Genetics and Metabolism
|
May 23, 2022
Time to harmonize mitochondrial syndrome nomenclature and classification: A consensus from the North American Mitochondrial Disease Consortium (NAMDC)
Valentina Emmanuele, Jaya Ganesh, Georgirene Vladutiu, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 18, 2007
N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR
Holly L Deak, John R Newcomb, Joseph J Nunes, et al.
The Journal of Pediatrics
|
August 4, 1999
The mitochondrial DNA C3303T mutation can cause cardiomyopathy and/or skeletal myopathy
C Bruno, D M Kirby, Y Koga, et al.
Antioxidants (Basel, Switzerland)
|
May 27, 2023
Online Home-Based Physical Activity Counteracts Changes of Redox-Status Biomarkers and Fitness Profiles during Treatment Programs in Postsurgery Female Breast Cancer Patients
Chantalle Moulton, Elisa Grazioli, Cristina Antinozzi, et al.
Nature
|
September 6, 2000
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
I Nishino, J Fu, K Tanji, et al.
Mitochondrion
|
January 13, 2010
Extensive screening system using suspension array technology to detect mitochondrial DNA point mutations
Yutaka Nishigaki, Hitomi Ueno, Jorida Coku, et al.
BMC Structural Biology
|
March 20, 2009
Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study
Maria A Argiriadi, Silvino Sousa, David Banach, et al.
Page
of 95